Skip to main content
SpringerLink
Log in

Imaging Androgen Receptor Function In Vivo

  • Chapter
  • First Online:
Androgen Action in Prostate Cancer

  • 818 Accesses

Abstract

Bioluminescence imaging (BLI) is a facile method for studying androgen receptor (AR) signaling during tumor progression in xenografts and genetic models of prostate cancer in mice. This chapter summarizes work where BLI and positron emission tomography coupled with CT were used to analyze AR-mediated transcriptional activity using gene expression-based imaging approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adams, J. Y., Johnson, M., Sato, M., Berger, F., Gambhir, S. S., Carey, M., Iruela-Arispe, M. L., and Wu, L.2002. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med8: 891–897.

    PubMed  CAS  Google Scholar 

  • Bok, R. A., and Small, E. J.2002. Bloodborne biomolecular markers in prostate cancer development and progression. Nat Rev Cancer2: 918–926.

    Article  PubMed  CAS  Google Scholar 

  • Burton, J. B., Johnson, M., Sato, M., Koh, S. B. S., Mulholland, D., Stout, D., Chatziioannou, A. F., Phelps, M. E., Wu, H., and Wu, L.2008. Adenovirus mediated gene expression imaging to detect sentinel lymph node metastasis of prostate cancer. Nat Med14: 882–888.

    Article  PubMed  CAS  Google Scholar 

  • Cleutjens, K. B., van der Korput, H. A., van Eekelen, C. C., van Rooij, H. C., Faber, P. W., and Trapman, J.1997. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol11: 148–161.

    Article  PubMed  CAS  Google Scholar 

  • Cleutjens, K. B., van Eekelen, C. C., van der Korput, H. A., Brinkman, A. O., and Trapman, J.1996. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem271: 6379–6388.

    Article  PubMed  CAS  Google Scholar 

  • Contag, C. H., and Bachmann, M. H.2002. Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng4: 235–260.

    Article  PubMed  CAS  Google Scholar 

  • Contag, C. H., Jenkins, D., Contag, P. R., and Negrin, R. S.2000. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia2: 41–52.

    Article  PubMed  CAS  Google Scholar 

  • Cruzalegui, F. H., Cano, E., and Treisman, R.1999. ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry. Oncogene18: 7948–7957.

    Article  PubMed  CAS  Google Scholar 

  • Dehdashti, F., Picus, J., Michalski, J. M., Dence, C. S., Siegel, B. A., Katzenellenbogen, J. A., and Welch, M. J.2005. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging32: 344–350.

    Article  PubMed  Google Scholar 

  • Dehm, S. M., and Tindall, D. J.2007. Androgen receptor structural and functional elements: role and regulation in prostate cancer. Mol Endocrinol21: 2855–2863.

    Article  PubMed  CAS  Google Scholar 

  • Ellwood-Yen, K., Wongvipat, J., and Sawyers, C.2006. Transgenic mouse model for rapid pharmacodynamic evaluation of antiandrogens. Cancer Res66: 10513–10516.

    Article  PubMed  CAS  Google Scholar 

  • Emami, K. H., and Carey, M.1992. A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. Embo J11: 5005–5012.

    PubMed  CAS  Google Scholar 

  • Gambhir, S. S.2002. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer2: 683–693.

    Article  PubMed  CAS  Google Scholar 

  • Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., and Greenberg, N. M.1996. Metastatic prostate cancer in a transgenic mouse. Cancer Res56: 4096–4102.

    PubMed  CAS  Google Scholar 

  • Gioeli, D., Mandell, J. W., Petroni, G. R., Frierson, H. F., Jr., and Weber, M. J.1999. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res59: 279–284.

    PubMed  CAS  Google Scholar 

  • Gregory, C. W., He, B., Johnson, R. T., Ford, O. H., Mohler, J. L., French, F. S., and Wilson, E. M.2001a. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res61: 4315–4319.

    CAS  Google Scholar 

  • Gregory, C. W., Johnson, R. T., Jr., Mohler, J. L., French, F. S., and Wilson, E. M.2001b. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res61: 2892–2898.

    CAS  Google Scholar 

  • Helms, M. W., Brandt, B. H., and Contag, C. H.2006. Options for visualizing metastatic disease in the living body. Contrib Microbiol13: 209–231.

    Article  PubMed  Google Scholar 

  • Hexdall, L., and Zheng, C. F.2001. Stable luciferase reporter cell lines for signal transduction pathway readout using GAL4 fusion transactivators. Biotechniques30: 1134–1138, 1140.

    PubMed  CAS  Google Scholar 

  • Hsieh, C. L., Xie, Z., Liu, Z. Y., Green, J. E., Martin, W. D., Datta, M. W., Yeung, F., Pan, D., and Chung, L. W.2005. A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals. J Mol Endocrinol35: 293–304.

    Article  PubMed  CAS  Google Scholar 

  • Hsieh, C. L., Xie, Z., Yu, J., Martin, W. D., Datta, M. W., Wu, G. J., and Chung, L. W.2007. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model. Prostate67: 685–691.

    Article  PubMed  Google Scholar 

  • Huang, W., Shostak, Y., Tarr, P., Sawyers, C., and Carey, M.1999. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J Biol Chem274: 25756–25768.

    Article  PubMed  CAS  Google Scholar 

  • Ignowski, J. M., and Schaffer, D. V.2004. Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells. Biotechnol Bioeng86: 827–834.

    Article  PubMed  CAS  Google Scholar 

  • Ilagan, R., Pottratz, J., Le, K., Zhang, L., Wong, S. G., Ayala, R., Iyer, M., Wu, L., Gambhir, S. S., and Carey, M.2006. Imaging mitogen-activated protein kinase function in xenograft models of prostate cancer. Cancer Res66: 10778–10785.

    Article  PubMed  CAS  Google Scholar 

  • Ilagan, R., Zhang, L. J., Pottratz, J., Le, K., Salas, S., Iyer, M., Wu, L., Gambhir, S. S., and Carey, M.2005. Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model. Mol Cancer Ther4: 1662–1669.

    Article  PubMed  CAS  Google Scholar 

  • Iyer, M., Salazar, F. B., Lewis, X., Zhang, L., Carey, M., Wu, L., and Gambhir, S. S.2004. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol Ther10: 545–552.

    Article  PubMed  CAS  Google Scholar 

  • Iyer, M., Salazar, F. B., Lewis, X., Zhang, L., Wu, L., Carey, M., and Gambhir, S. S.2005a. Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy. Transgenic Res14: 47–55.

    Article  CAS  Google Scholar 

  • Iyer, M., Salazar, F. B., Wu, L., Carey, M., and Gambhir, S. S.2006. Bioluminescence imaging of systemic tumor targeting using a prostate-specific lentiviral vector. Hum Gene Ther17: 125–132.

    Article  PubMed  CAS  Google Scholar 

  • Iyer, M., Sato, M., Johnson, M., Gambhir, S. S., and Wu, L.2005b. Applications of molecular imaging in cancer gene therapy. Curr Gene Ther5: 607–618.

    Article  CAS  Google Scholar 

  • Iyer, M., Wu, L., Carey, M., Wang, Y., Smallwood, A., and Gambhir, S. S.2001. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A98: 14595–14600.

    Article  PubMed  CAS  Google Scholar 

  • Jacobson, O., Bechor, Y., Icar, A., Novak, N., Birman, A., Marom, H., Fadeeva, L., Golan, E., Leibovitch, I., Gutman, M., et al.2005. Prostate cancer PET bioprobes: synthesis of [18F]-radiolabeled hydroxyflutamide derivatives. Bioorg Med Chem13: 6195–6205.

    Article  PubMed  CAS  Google Scholar 

  • Johnson, M., Sato, M., Burton, J., Gambhir, S. S., Carey, M., and Wu, L.2005. Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach. Mol Imaging4: 463–472.

    PubMed  Google Scholar 

  • Klein, K. A., Reiter, R. E., Redula, J., Moradi, H., Zhu, X. L., Brothman, A. R., Lamb, D. J., Marcelli, M., Belldegrun, A., Witte, O. N., and Sawyers, C. L.1997. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med3: 402–408.

    Article  PubMed  CAS  Google Scholar 

  • Latham, J. P., Searle, P. F., Mautner, V., and James, N. D.2000. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Cancer Res60: 334–341.

    PubMed  CAS  Google Scholar 

  • Marais, R., Wynne, J., and Treisman, R.1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell73: 381–393.

    Article  PubMed  CAS  Google Scholar 

  • Marcelli, M., Stenoien, D. L., Szafran, A. T., Simeoni, S., Agoulnik, I. U., Weigel, N. L., Moran, T., Mikic, I., Price, J. H., and Mancini, M. A.2006. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. J Cell Biochem98: 770–788.

    Article  PubMed  CAS  Google Scholar 

  • Massoud, T. F., and Gambhir, S. S.2003. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev17: 545–580.

    Article  PubMed  CAS  Google Scholar 

  • Mohler, J. L., Gregory, C. W., Ford, O. H., 3rd, Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., and French, F. S.2004. The androgen axis in recurrent prostate cancer. Clin Cancer Res10: 440–448.

    Article  PubMed  CAS  Google Scholar 

  • Parent, E. E., Carlson, K. E., and Katzenellenbogen, J. A.2007. Synthesis of 7alpha-(fluoromethyl)dihydrotestosterone and 7alpha-(fluoromethyl)nortestosterone, structurally paired androgens designed to probe the role of sex hormone binding globulin in imaging androgen receptors in prostate tumors by positron emission tomography. J Org Chem72: 5546–5554.

    Article  PubMed  CAS  Google Scholar 

  • Parent, E. E., Dence, C. S., Sharp, T. L., Welch, M. J., and Katzenellenbogen, J. A.2006. Synthesis and biological evaluation of a fluorine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[18F]fluoro-4-nitronaphthyl)-cis-5-norbornene-endo-2,3-dicarboxylic imide. Nucl Med Biol33: 615–624.

    Article  PubMed  CAS  Google Scholar 

  • Rauen, K. A., Sudilovsky, D., Le, J. L., Chew, K. L., Hann, B., Weinberg, V., Schmitt, L. D., and McCormick, F.2002. Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res62: 3812–3818.

    PubMed  CAS  Google Scholar 

  • Reid, K. J., Hendy, S. C., Saito, J., Sorensen, P., and Nelson, C. C.2001. Two classes of androgen receptor elements mediate cooperativity through allosteric interactions. J Biol Chem276: 2943–2952.

    Article  PubMed  CAS  Google Scholar 

  • Riegman, P. H., Vlietstra, R. J., van der Korput, J. A., Brinkmann, A. O., and Trapman, J.1991. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol5: 1921–1930.

    Article  PubMed  CAS  Google Scholar 

  • Roudier, M. P., True, L. D., Higano, C. S., Vesselle, H., Ellis, W., Lange, P., and Vessella, R. L.2003. Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol34: 646–653.

    Article  PubMed  Google Scholar 

  • Sadowski, I., Ma, J., Triezenberg, S., and Ptashne, M.1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature335: 563–564.

    Article  PubMed  CAS  Google Scholar 

  • Sato, M., Figueiredo, M. L., Burton, J. B., Johnson, M., Chen, M., Powell, R., Gambhir, S. S., Carey, M., and L., W. 2008. Configurations of a two-tiered amplified gene expression system vector to improve the specificity of in vivo prostate cancer imaging. Gene Therapy (under revision).

    Google Scholar 

  • Sato, M., Johnson, M., Zhang, L., Gambhir, S. S., Carey, M., and Wu, L.2005. Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer. Clin Cancer Res11: 3743–3749.

    Article  PubMed  CAS  Google Scholar 

  • Sato, M., Johnson, M., Zhang, L., Zhang, B., Le, K., Gambhir, S. S., Carey, M., and Wu, L.2003. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy. Mol Ther8: 726–737.

    Article  PubMed  CAS  Google Scholar 

  • Schoder, H., and Larson, S. M.2004. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med34: 274–292.

    Article  PubMed  Google Scholar 

  • Schuur, E. R., Henderson, G. A., Kmetec, L. A., Miller, J. D., Lamparski, H. G., and Henderson, D. R.1996. Prostate-specific antigen expression is regulated by an upstream enhancer. J Biol Chem271: 7043–7051.

    Article  PubMed  CAS  Google Scholar 

  • Seethammagari, M. R., Xie, X., Greenberg, N. M., and Spencer, D. M.2006. EZC-prostate models offer high sensitivity and specificity for noninvasive imaging of prostate cancer progression and androgen receptor action. Cancer Res66: 6199–6209.

    Article  PubMed  CAS  Google Scholar 

  • Shah, R. B., Mehra, R., Chinnaiyan, A. M., Shen, R., Ghosh, D., Zhou, M., Macvicar, G. R., Varambally, S., Harwood, J., Bismar, T. A., et al.2004. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res64: 9209–9216.

    Article  PubMed  CAS  Google Scholar 

  • Taplin, M. E.2007. Drug insight: role of the androgen receptor in the development and progression of prostate cancer. Nat Clin Pract Oncol4: 236–244.

    Article  PubMed  CAS  Google Scholar 

  • Weber, M. J., and Gioeli, D.2004. Ras signaling in prostate cancer progression. J Cell Biochem91: 13–25.

    Article  PubMed  CAS  Google Scholar 

  • Wu, L., Johnson, M., and Sato, M.2003. Transcriptionally targeted gene therapy to detect and treat cancer. Trends Mol Med9: 421–429.

    Article  PubMed  CAS  Google Scholar 

  • Wu, L., Matherly, J., Smallwood, A., Adams, J. Y., Billick, E., Belldegrun, A., and Carey, M.2001. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors. Gene Ther8: 1416–1426.

    Article  PubMed  CAS  Google Scholar 

  • Xie, X., Zhao, X., Liu, Y., Young, C. Y., Tindall, D. J., Slawin, K. M., and Spencer, D. M.2001. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter. Hum Gene Ther12: 549–561.

    Article  PubMed  CAS  Google Scholar 

  • Ye, X., Han, S. J., Tsai, S. Y., DeMayo, F. J., Xu, J., Tsai, M. J., and O'Malley, B. W.2005. Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Proc Natl Acad Sci U S A102: 9487–9492.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, J., Gao, N., Kasper, S., Reid, K., Nelson, C., and Matusik, R. J.2004. An androgen-dependent upstream enhancer is essential for high levels of probasin gene expression. Endocrinology145: 134–148.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, J., Thomas, T. Z., Kasper, S., and Matusik, R. J.2000. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology141: 4698–4710.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, L., Adams, J. Y., Billick, E., Ilagan, R., Iyer, M., Le, K., Smallwood, A., Gambhir, S. S., Carey, M., and Wu, L.2002. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol Ther5: 223–232.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, L., Johnson, M., Le, K. H., Sato, M., Ilagan, R., Iyer, M., Gambhir, S. S., Wu, L., and Carey, M.2003. Interrogating androgen receptor function in recurrent prostate cancer. Cancer Res63: 4552–4560.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biological Chemistry, rDavid Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA

    Michael Carey

Authors
  1. Michael Carey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lily Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Carey .

Editor information

James Mohler Donald Tindall

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Carey, M., Wu, L. (2009). Imaging Androgen Receptor Function In Vivo. In: Mohler, J., Tindall, D. (eds) Androgen Action in Prostate Cancer. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69179-4_4

Download citation

Publish with us

Policies and ethics

Search

Navigation